Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 13 (1), 11-26

WNT Signalling Pathways as Therapeutic Targets in Cancer

Affiliations
Review

WNT Signalling Pathways as Therapeutic Targets in Cancer

Jamie N Anastas et al. Nat Rev Cancer.

Abstract

Since the initial discovery of the oncogenic activity of WNT1 in mouse mammary glands, our appreciation for the complex roles for WNT signalling pathways in cancer has increased dramatically. WNTs and their downstream effectors regulate various processes that are important for cancer progression, including tumour initiation, tumour growth, cell senescence, cell death, differentiation and metastasis. Although WNT signalling pathways have been difficult to target, improved drug-discovery platforms and new technologies have facilitated the discovery of agents that can alter WNT signalling in preclinical models, thus setting the stage for clinical trials in humans.

Similar articles

See all similar articles

Cited by 688 PubMed Central articles

See all "Cited by" articles

References

    1. EMBO J. 2001 Sep 3;20(17):4912-22 - PubMed
    1. Oncogene. 2001 Feb 1;20(5):645-53 - PubMed
    1. Clin Cancer Res. 2008 Oct 15;14 (20):6556-63 - PubMed
    1. Oncogene. 2008 Nov 27;27(56):7118-30 - PubMed
    1. Cancer Cell. 2012 Mar 20;21(3):348-61 - PubMed

Publication types

LinkOut - more resources

Feedback